SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Caribou Biosciences, Inc. (CRBU) News

Follow Caribou Biosciences, Inc. (CRBU) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 11 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol CRBU Asset equity Sector Markets 90 days 10 Last 0.2954 Updated Nov 09, 2026, 12:01 PM UTC Open live news feed Open CRBU chart & news
M Caribou Biosciences Q3'26 Earnings Preview: EPS Estimate at $(0.26) Caribou Biosciences is expected to report Q3'26 results on November 10. Revenue is estimated at $1.60 million; EPS is estimated at $(0.26). EQUITY | Nov 09, 2026, 12:01 PM UTC M Caribou Biosciences Q3 Revenue Declines; Company to Discontinue Lead Clinical Program Caribou Biosciences reported a decline in Q3 revenue and said it will discontinue its lead clinical program. EQUITY | Nov 05, 2026, 09:56 PM UTC L Caribou Biosciences 3Q 2026: Revenue $1.61M, EPS ($0.25) — 10-Q Summary Caribou Biosciences’ third-quarter revenue declined as the prior-year period included $0.6 million under an expired Pfizer agreement. Net loss narrowed, reflecting lower research and development and general and administr EARNINGS | Nov 05, 2026, 09:17 PM UTC M Caribou Biosciences Reports Q3 2026 Net Loss of $26.6 Million Caribou reported a third-quarter net loss of $26.6 million, or $0.25 per share, versus a $27.5 million loss, or $0.30 per share, a year earlier. Revenue was $1.6 million; cash, equivalents and marketable securities total EQUITY | Nov 05, 2026, 09:16 PM UTC H Deal Dispatch: Uber Buys ezCater For $2.3B, Skydance Takes Over Warner Bros., True Food Kitchen Bankruptcy New On The Block Caribou Biosciences, Inc. (NASDAQ: CRBU ), a clinical-stage CRISPR genome-editing biopharmaceutical company, is exploring strategic alternatives to maximize stockholder value and plans to discontinue fur LIVE | Oct 09, 2026, 07:03 PM UTC H Nasdaq Falls Over 100 Points; US Crude Inventories Decline U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 100 points on Wednesday. The Dow traded down 0.92% to 51,045.57 while the NASDAQ declined 0.41% to 27,485.79. The S&P 500 also fell, LIVE | Oct 07, 2026, 04:02 PM UTC H CRBU Stock Plummets 35% Premarket on RBC Target Cut Caribou Biosciences (CRBU) shares fell over 35% in pre-market trading after RBC Capital Markets slashed its price target by 90% following the company's decision to scale back its CAR-T cancer-drug development programs. EQUITY | Oct 07, 2026, 10:49 AM UTC H Stock Market Today: Dow Jones, Nasdaq 100 Futures Decline as Iran Mocks US Economy, Trump Sparks Bipartisan Backlash — STZ, PENG, LEVI in Focus U.S. stocks look set to open on a negative note on Wednesday, with futures of the Dow Jones, S&P 500 and Nasdaq 100 indices falling, following Tuesday’s higher close. Political fallout and rising Middle East tensions dom LIVE | Oct 07, 2026, 09:41 AM UTC H Why Penguin Solutions Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket Shares of Penguin Solutions, Inc. (NYSE: PENG ) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued FY27 EPS guidance above estimates. The compan LIVE | Oct 07, 2026, 08:38 AM UTC H Levi Strauss, Constellation Brands and 3 Stocks to Watch Heading Into Wednesday With U.S. stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Levi Strauss & Co. (NYSE: LEVI ) to post quarterly earnings of 36 LIVE | Oct 07, 2026, 06:27 AM UTC L Caribou Biosciences reports Q2 2026 results, issues business update Caribou Biosciences (CRBU) reports second quarter 2026 financial results and provides a business update, according to TradeXchange Newsdesk; no specific figures or guidance details were supplied in the feed. EARNINGS | Aug 13, 2026, 08:07 PM UTC